X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Lupin Ltd with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN vs ABBOTT INDIA - Comparison Results

LUPIN    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LUPIN ABBOTT INDIA LUPIN/
ABBOTT INDIA
 
P/E (TTM) x 41.4 38.5 107.4% View Chart
P/BV x 2.5 10.0 25.5% View Chart
Dividend Yield % 0.7 0.7 94.5%  

Financials

 LUPIN   ABBOTT INDIA
EQUITY SHARE DATA
    LUPIN
Mar-18
ABBOTT INDIA
Mar-18
LUPIN/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs1,4656,110 24.0%   
Low Rs7273,996 18.2%   
Sales per share (Unadj.) Rs349.61,552.2 22.5%  
Earnings per share (Unadj.) Rs5.6188.8 2.9%  
Cash flow per share (Unadj.) Rs29.6196.4 15.1%  
Dividends per share (Unadj.) Rs5.0055.00 9.1%  
Dividend yield (eoy) %0.51.1 41.9%  
Book value per share (Unadj.) Rs300.3796.6 37.7%  
Shares outstanding (eoy) m452.0821.25 2,127.4%   
Bonus/Rights/Conversions ESOPS--  
Price / Sales ratio x3.13.3 96.3%   
Avg P/E ratio x197.226.8 736.9%  
P/CF ratio (eoy) x37.125.7 144.1%  
Price / Book Value ratio x3.66.3 57.5%  
Dividend payout %90.029.1 308.8%   
Avg Mkt Cap Rs m495,502107,376 461.5%   
No. of employees `00017.03.3 513.0%   
Total wages/salary Rs m28,6473,937 727.7%   
Avg. sales/employee Rs Th9,273.69,929.3 93.4%   
Avg. wages/employee Rs Th1,681.01,185.1 141.8%   
Avg. net profit/employee Rs Th147.41,207.7 12.2%   
INCOME DATA
Net Sales Rs m158,04232,985 479.1%  
Other income Rs m1,5041,170 128.5%   
Total revenues Rs m159,54534,155 467.1%   
Gross profit Rs m31,4755,245 600.1%  
Depreciation Rs m10,859162 6,707.0%   
Interest Rs m2,04438 5,349.5%   
Profit before tax Rs m20,0766,215 323.0%   
Minority Interest Rs m-710-   
Prior Period Items Rs m350-   
Extraordinary Inc (Exp) Rs m-14,6440-   
Tax Rs m2,8852,203 131.0%   
Profit after tax Rs m2,5134,012 62.6%  
Gross profit margin %19.915.9 125.2%  
Effective tax rate %14.435.4 40.5%   
Net profit margin %1.612.2 13.1%  
BALANCE SHEET DATA
Current assets Rs m122,09522,655 538.9%   
Current liabilities Rs m50,9566,681 762.7%   
Net working cap to sales %45.048.4 92.9%  
Current ratio x2.43.4 70.7%  
Inventory Days Days8565 130.6%  
Debtors Days Days12029 411.4%  
Net fixed assets Rs m129,876835 15,545.3%   
Share capital Rs m904213 425.5%   
"Free" reserves Rs m134,86616,715 806.9%   
Net worth Rs m135,77116,928 802.1%   
Long term debt Rs m64,2450-   
Total assets Rs m263,05424,162 1,088.7%  
Interest coverage x10.8163.7 6.6%   
Debt to equity ratio x0.50-  
Sales to assets ratio x0.61.4 44.0%   
Return on assets %1.716.8 10.3%  
Return on equity %1.923.7 7.8%  
Return on capital %3.736.9 10.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m53,141369 14,419.4%   
Fx outflow Rs m19,3353,807 507.9%   
Net fx Rs m33,807-3,438 -983.3%   
CASH FLOW
From Operations Rs m17,5121,527 1,146.8%  
From Investments Rs m-14,073-2,148 655.0%  
From Financial Activity Rs m-14,921-1,024 1,456.7%  
Net Cashflow Rs m-11,482-1,646 697.7%  

Share Holding

Indian Promoters % 46.6 0.0 -  
Foreign collaborators % 0.2 75.0 0.3%  
Indian inst/Mut Fund % 11.3 7.9 143.0%  
FIIs % 31.9 0.1 31,900.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.1 17.1 59.1%  
Shareholders   98,259 18,270 537.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LUPIN With:   SANOFI INDIA  JUBILANT LIFE SCIENCES  DISHMAN PHARMA  STERLING BIOTECH  NATCO PHARMA  

Compare LUPIN With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

March Quarter Results, Rising Crude Oil Prices, and Top Cues in Focus Today(Pre-Open)

On Friday, share markets in India traded on a positive note throughout the day and ended above the 39,000-mark.

Related Views on News

LUPIN Announces Quarterly Results (4QFY19); Net Profit Down 1.5% (Quarterly Result Update)

May 17, 2019 | Updated on May 17, 2019

For the quarter ended March 2019, LUPIN has posted a net profit of Rs 3 bn (down 1.5% YoY). Sales on the other hand came in at Rs 44 bn (up 77.8% YoY). Read on for a complete analysis of LUPIN's quarterly results.

LUPIN LTD Announces Quarterly Results (3QFY19); Net Profit Down 149.7% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, LUPIN LTD has posted a net profit of Rs 2 bn (down 149.7% YoY). Sales on the other hand came in at Rs 45 bn (up 78.0% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (2QFY19); Net Profit Up 0.1% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

My Top 7 Stocks to Buy as Modi Returns to Power(The 5 Minute Wrapup)

May 23, 2019

The Modi government is all set to come back to power. With a stable government at the centre, how should you play the stock market?

What Makes TVS Srichakra and CCL Products a Cut Above the Rest?(The 5 Minute Wrapup)

May 17, 2019

Despite the commodity nature of their businesses, these two stocks have rewarded shareholders well.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN SHARE PRICE


May 24, 2019 (Close)

TRACK LUPIN

COMPARE LUPIN WITH

MARKET STATS